Evaluación y tratamiento de la Infertilidad


1: Lancet  2002 Jul 13;360(9327):151-9
Female subfertility.
Evers JL.
Department of Obstetrics and Gynaecology, Research Institute GROW, Academisch ziekenhuis Maastricht, and Maastricht University, Maastricht, Netherlands.
With an average monthly fecundity rate of only 20%, human beings are not fertile mammals. 10-15% of couples have difficulties conceiving, or conceiving the number of children they want, and seek specialist fertility care at least once during their reproductive lifetime. Dependent on the two main factors that determine subfertility, duration of childlessness and age of the woman, three questions need to be addressed before treatment is offered. Is it time to start the routine fertility investigation?--ie, has sufficient exposure to the chance of conception taken place? Are cost-effective, safe, and reliable treatments available for the disorder diagnosed? And, should the couple be referred straightaway for assisted reproduction?
Publication Types:

2: BMJ  2002 Jul 6;325(7354):28-32 [Texto completo]
Management of infertility.
Cahill DJ, Wardle PG.
University of Bristol Division of Obstetrics and Gynaecology, St Michael's Hospital, Bristol BS2 8EG.
Publication Types:

3: Arch Dis Child  2001 Apr;84(4):355-9 [Texto completo]
Fertility preservation for children treated for cancer (1): scientific advances and research dilemmas.
Grundy R, Gosden RG, Hewitt M, Larcher V, Leiper A, Spoudeas HA, Walker D, Wallace WH.
Institute of Child Health, University of Birmingham, Whittall Street, Birmingham B4 6NH, UK.
Publication Types:

4: Rev Med Interne  2001 Feb;22(2):111-7
Ovulation induction, lupus and antiphospholipids [Article in French]
Huong DL, Wechsler B, Piette JC.
Publication Types:

5: Clin Obstet Gynecol  2001 Mar;44(1):29-35
Antiphospholipid antibodies and infertility.
Porter TF.
University of Utah Health Sciences, Intermountain Health Care, Salt Lake City, Utah, USA.
Publication Types:

6: Obstet Gynecol Clin North Am  2000 Sep;27(3):473-86
Infertility. Contemporary office-based evaluation and treatment.
Penzias AS.
Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts, USA.
Infertility is a common condition that is highly treatable. Couples can help themselves by recognizing that they have a problem, and practitioners can help patients by recognizing who requires an infertility investigation and when they need it. Instituting a clear and comprehensive evaluation will enable patients who need treatment to achieve their goals.
Publication Types:

7: Curr Opin Urol  2000 Jul;10(4):359-62
Male infertility: recent advances and a look towards the future.
Lamb DJ, Lipshultz LI.
Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.
The past decade has witnessed clinical and basic scientific advances that have revolutionized the diagnosis and treatment of the infertile male. Advances in the clinic and laboratory have resulted in men who were previously thought to be hopelessly infertile, but who are now able to conceive their own biologic offspring. In the future, we believe that the laboratory will continue to play a key role in advancing our ability both to diagnose and to treat the infertile male. We summarize here some of the major advances of the past decade that have influenced our treatment and our understanding of the etiology of male infertility. When possible, clinical innovations and advances in basic science are discussed in combination in order to emphasize the translational importance of reproductive research.
Publication Types:

8: Postgrad Med  2000 Feb;107(2):235-9, 242, 245
Shattering the myths about male infertility. Treatment of male factors may be more successful and cost-effective than you think.
Sandlow JI.
Department of Urology, University of Iowa College of Medicine, Iowa City 52242-1089, USA.
Male factors play a role in up to half of subfertile couples, contrary to the myth that male factors rarely play a role. In this article, Dr Sandlow counters this and other myths about male infertility and suggests that primary care physicians can increase a couple's chance of conceiving by evaluating for male as well as female factors. This article will also help primary care physicians provide appropriate education and treatment, as well as determine when to make a referral to a male-infertility specialist.
Publication Types:

9: Clin Obstet Gynecol  2000 Dec;43(4):854-88
Evaluation and treatment of male infertility.
Silber SJ.
Infertility Center of St. Louis, St. Luke's Hospital, MO 63017, USA.
Publication Types:

10: Clin Obstet Gynecol  2000 Dec;43(4):844-53
Evaluation of the couple with infertility in a managed care environment.
Silverberg KM.
Texas Fertility Center, Austin 78705, USA.
The classic infertility evaluation is a costly experience for many couples. In the new era of managed care, it may be possible to perform a targeted evaluation that, while significantly lowering the total cost, will not impair our ability to correctly diagnose the cause of a couple's infertility. When combined with algorithms for streamlined treatment, it may be possible to significantly reduce the cost for the diagnosis and treatment of infertility.
Publication Types:

11: Urol Clin North Am  1999 Aug;26(3):555-93, vi
Testicular biopsy. Contemporary interpretation.
Nistal M, Paniagua R.
Department of Pathology, La Paz Hospital, Madrid, Spain.
Biopsy of the testis is not universally accepted in contrast with biopsies of other organs. The pathologist studies and reports on the pathophysiology of the testicular biopsy specimen. Methodology requires the inclusion of qualitative and quantitative studies, the evaluation of the lesion's evolution (prognosis), and, often, therapeutic advice regarding treatment. Cooperation between pathologists and clinicians optimizes the utility of the biopsy for the patient.
Publication Types:



Envia tu Sugerencia